MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary


NHS Improvement Patient Safety Alert

 November 2016: Risk of severe harm and death due to withdrawing insulin from pen devices. A patient safety alert has been issued to warn NHS providers of the risk of severe harm and death if an insulin needle and syringe is used to administer insulin withdrawn directly from a pen device or replacement cartridge.

Drug Safety Update

April 2018: Risk of mix-ups between insulin Fiasp (fast-acting insulin aspart) and Tresiba (basal insulin degludec)

NICE guidance

 NG17 Type 1 diabetes in adults : diagnosis and management, updated July 2016

 NG28 Type 2 diabetes in adults: diagnosis and management, updated May 2017

 NG3 Diabetes in pregnancy: management from preconception to the postnatal period, updated August 2015

Local guidance

 Variable rate intravenous insulin infusion (VRIII) guideline

 How to set up VRIII

 Quick reference tool for the use of VRIII

 Starting and stopping VRIII summary sheet

 Safe discontinuation of VRIII

 Hypoglycaemia and hyperglycaemia after VRIII

 Concomitant fluids with VRIII

 Blood glucose monitoring chart and an algorithm for the treatment and management of hypoglycaemia

It is recommended that when prescribing insulins the word "unit" is not abbreviated.